Order Article Reprints

Lin HS, Ding Q, Lichner Z, Kim SS, Saleeb R, Farag M, Di Meo A, Plant P, Kaldas M, Bjarnason GA, et al. The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance. Journal of Clinical Medicine. 2022; 11(2):369. https://doi.org/10.3390/jcm11020369

Lin, Harrison Sicheng, Qiang Ding, Zsuzsanna Lichner, Sung Sun Kim, Rola Saleeb, Mina Farag, Ashley Di Meo, Pamela Plant, Mirit Kaldas, Georg Arnold Bjarnason, and et al. 2022. "The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance" Journal of Clinical Medicine 11, no. 2: 369. https://doi.org/10.3390/jcm11020369

Lin, H. S., Ding, Q., Lichner, Z., Kim, S. S., Saleeb, R., Farag, M., Di Meo, A., Plant, P., Kaldas, M., Bjarnason, G. A., & Yousef, G. M. (2022). The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance. Journal of Clinical Medicine, 11(2), 369. https://doi.org/10.3390/jcm11020369